Reviewed clinical summary · Source-linked · Educational use only

Can Moxibustion Plus Low-Dose Tadalafil Improve Erectile Dysfunction in Diabetic Patients?

Clinical Bottom Line

A three-arm RCT finds moxibustion plus low-dose tadalafil outperforms either alone for diabetic erectile dysfunction, in an unblinded single-centre setting. PICO summary and commentary.

Summary: In a three-arm trial in men with diabetic erectile dysfunction and a traditional Chinese medicine pattern of qi deficiency with blood stasis, moxibustion combined with low-dose daily tadalafil achieved a 90% effectiveness rate, well above either moxibustion or tadalafil alone, with improved erectile scores and penile blood flow.

PICO Summary

ElementDetail
Population90 men with diabetes-induced erectile dysfunction and qi-deficiency/blood-stasis syndrome; single centre, China.
InterventionMild moxibustion at ST36, SP6, SP9 every other day plus tadalafil 5 mg daily for 4 weeks.
ComparisonMoxibustion alone or tadalafil 5 mg daily alone.
OutcomeTotal effectiveness 90.0% (combination) vs 46.7% (moxibustion) and 60.0% (tadalafil) (p<0.05). Combination improved IIEF-5 and EHS scores and lowered TCM symptom scores more than either alone, with greater peak systolic velocity on penile Doppler. No significant adverse effects.
RCT Zhonghua Nan Ke Xue · 2025

Moxibustion + tadalafil for diabetic ED

RCT · diabetic erectile dysfunction · 4 weeks

Trial design
Men with diabetic ED Enrolled & assessed RANDOMISED 1:1:1 Combination Moxibustion + tadalafil n = 30 Tadalafil Tadalafil 5 mg daily n = 30 Total effectiveness rate at 4 weeks
Proportion reaching endpoint
RR 1.50 % effective 90% Combination 60% Tadalafil ARR+30.0 pp
Combination
90.0%
Effective
Tadalafil
60.0%
Effective
Moxibustion
46.7%
Effective
Difference
+30.0 pp
vs tadalafil
⬡ Bottom Line

Moxibustion added to low-dose daily tadalafil raised the total effectiveness rate to 90% versus 60% with tadalafil alone, but the trial was small, single-centre and unblinded.

Expert Commentary

Diabetic erectile dysfunction responds poorly to PDE5 inhibitors in up to half of men, so interest in adjuncts is reasonable, and the combination here did outperform both monotherapies on effectiveness and on objective penile Doppler flow, which is more persuasive than symptom scores alone. I hold a measured view, though, for reasons intrinsic to this kind of trial. Moxibustion cannot be blinded, so expectation effects are hard to exclude, the study is single-centre with 90 patients over only four weeks, and the framing rests on a traditional Chinese medicine syndrome that does not map cleanly onto how most clinicians outside that tradition select patients. A daily low-dose tadalafil arm is itself a legitimate comparator, and the increment attributed to moxibustion should be read in that unblinded context. Can I use this with my patients? Cautiously and only as an optional adjunct. For a diabetic man with a partial response to PDE5 inhibitors who is interested in acupuncture-based therapy and has access to a competent practitioner, it is a low-risk addition, but I would continue optimising glycaemic control and standard ED management as the foundation and not present moxibustion as proven. Larger, sham-controlled trials would help.

References

Liu T, Yang ZX, Xu Y, et al. Moxibustion combined with low-dose tadalafil for diabetes mellitus-induced erectile dysfunction: a prospective, single-center, three-arm randomized controlled trial. Zhonghua Nan Ke Xue. 2025;31(2):55–60. (Article in Chinese.) PMID:40783974

Educational use: Hormone Insight is intended for healthcare professionals and learners. Interpret each summary alongside the primary source, local guidance, and patient-specific clinical judgement.

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

© 2024-2026 Hormone Insight. All rights reserved.